eLife26d
Structure of the human CTF18 clamp loader bound to PCNA
Briola and co-authors determined the structure of the human CTF18 clamp loader bound to PCNA to high resolution, analyzed the structure, and tested a new mechanism involving a human-specific Ctf18 ...
Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
NDAQ:ACXP) Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules ...
Dyadic International provides update on efforts related to Alternative Proteins
At Dyadic, we remain committed to leveraging our innovative C1 and Dapibus protein production platforms to address some of the most pressing ...
eLife20h
Dilated cardiomyopathy-associated RNA Binding Motif Protein 20 regulates long pre-mRNAs in neurons
This important study reveals a new mechanism for gene regulation in neurons by an RNA binding protein called RBM20 previously studied in the heart. The methods used are compelling, including the ...
American Association of Individual Investors20d
Which Is a Better Investment, Bio-Rad Laboratories, Inc. or Bruker Corporation Stock?
Learn more about whether Bio-Rad Laboratories, Inc. or Bruker Corporation is a better investment based on AAII's A+ Investor ...
News Medical on MSN2d
Investigating the impact of CircRNAs on cancer progression and drug resistance
The researcher has given an overview on the regulatory network of extracellular circRNAs in cancer and their impact on cancer drug resistance. In order to propagate malignancy, circRNAs shuttle ...
Acurx Pharmaceuticals, Inc.: Acurx Receives Positive Regulatory Guidance from EMA for Ibezapolstat Phase 3 Program for C. Difficile Infection (CDI)
Acurx has now received positive written responses from the EMA (European Medicines Agency) under its Scientific Advice Procedure that the clinical, non-clinical and ...